Author

Prasad Kopparapu

Observed names: P Kopparapu, P R Kopparapu, Prasad R. Kopparapu, Prasad Rao Kopparapu

Institution: Indiana University School of Medicine

Observed institutions: Oregon State University, Nationwide Children's Hospital, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Indiana University School of Medicine, Vanderbilt University Medical Center

ORCID: 0000-0002-1999-7942

Observed ORCID: 0000-0002-1999-7942

OpenAlex ID: A5055839880

Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes

2024 · Simon Heeke, Carl M. Gay, et al. · Cancer Cell · 130

The Anti-Inflammatory Drug Leflunomide Is an Agonist of the Aryl Hydrocarbon Receptor

2010 · Edmond F. O'Donnell, Katerine S. Saili, et al. · PLoS ONE · 123

PDF

The Aryl Hydrocarbon Receptor Mediates Leflunomide-Induced Growth Inhibition of Melanoma Cells

2012 · Edmond F. O’Donnell, Prasad Rao Kopparapu, et al. · PLoS ONE · 80

PDF

Benzimidazoisoquinolines: A New Class of Rapidly Metabolized Aryl Hydrocarbon Receptor (AhR) Ligands that Induce AhR-Dependent Tregs and Prevent Murine Graft-Versus-Host Disease

2014 · Sumit Punj, Prasad Kopparapu, et al. · PLoS ONE · 58

PDF

Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer

2023 · Lavanya Sivapalan, Wade T. Iams, et al. · Clinical Cancer Research · 50

PDF

Anti-androgen flutamide suppresses hepatocellular carcinoma cell proliferation via the aryl hydrocarbon receptor mediated induction of transforming growth factor-β1

2015 · D C Koch, H S Jang, et al. · Oncogene · 49

Induction of apoptosis and suppression of tumor growth by Nur77-derived Bcl-2 converting peptide in chemoresistant lung cancer cells

2018 · Martin C. Pearce, John T. Gamble, et al. · Oncotarget · 44

PDF

Beyond Programmed Death-Ligand 1: B7-H6 Emerges as a Potential Immunotherapy Target in SCLC

2021 · Portia L. Thomas, Sarah M. Groves, et al. · Journal of Thoracic Oncology · 32

PDF

Blood-Based Surveillance Monitoring of Circulating Tumor DNA From Patients With SCLC Detects Disease Relapse and Predicts Death in Patients With Limited-Stage Disease

2020 · Wade T. Iams, Prasad R. Kopparapu, et al. · JTO Clinical and Research Reports · 22

PDF

Circulating Tumor DNA as a Biomarker of Radiographic Tumor Burden in SCLC

2020 · Jarrod T. Smith, Aneri Balar, et al. · JTO Clinical and Research Reports · 16

PDF

Rapidly fatal pneumonitis from immunotherapy and concurrent SARS-CoV-2 infection in a patient with newly diagnosed lung cancer

2020 · Christine M. Lovly, Kelli L. Boyd, et al. · medRxiv · 13

PDF

11‐Cl‐BBQ , a select modulator of AhR ‐regulated transcription, suppresses lung cancer cell growth via activation of p53 and p27 Kip1

2022 · Bach D. Nguyen, Brenna L. Stevens, et al. · FEBS Journal · 12

PDF

Identification and Characterization of a Small Molecule Bcl-2 Functional Converter

2024 · Prasad R. Kopparapu, Martin C. Pearce, et al. · Cancer Research Communications · 5

PDF

Small Molecule Functional Converter of B-Cell Lymphoma-2 (Bcl-2) Suppresses Breast Cancer Lung Metastasis

2024 · Prasad R. Kopparapu, Christiane V. Löhr, et al. · ACS Pharmacology & Translational Science · 2

PDF

Fig S1 from Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer

2023 · Lavanya Sivapalan, Wade T. Iams, et al. · 1

PDF

Abstract 3375: Molecular subtyping of circulating tumor cells in patients with small cell lung cancer

2022 · Prasad R. Kopparapu, Melinda Duplessis, et al. · Cancer Research · 1

Abstract 715: Circulating tumor DNA as a potential biomarker of radiographic tumor burden in small cell lung cancer

2020 · Jarrod T. Smith, Aneri Balar, et al. · Cancer Research · 1

Fig S1 from Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer